Founded in 2000, Benchmark has been built through organic innovation and strategic acquisitions. In 2013, we listed on the AIM market of the London Stock Exchange.
Launched Benchmark Genetics in Chile
Becomes one of only 5 companies to feature in the London Stock Exchange Group’s ‘1000 Companies to Inspire Britain’ report for 5th Consecutive year.
Reached 1,000 employees
Signed a long-term agreement with SalMar, one of the world’s leading salmon producers, to provide genetics, health and knowledge services to the company.
Added shrimp to our aquaculture breeding business through the acquisition of a South American shrimp breeding programme.
Acquired the number 1 advanced aquaculture nutrition provider, INVE Aquaculture.
Added Norwegian, Akvaforsk Genetics Center AS, and tilapia breeding company, Spring Genetics to strengthen our genetics offering.
Completed an acquisition of the second and third-ranked international salmon breeding companies, SalmoBreed and StofnFiskur.
Floated on the London Stock Exchange AIM market.
Acquired Novartis’s vaccine manufacturing plant in Braintree, UK.
Benchmark is established to drive improvements in the food supply chain.